Plain-English translation of NCT07417605 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new advanced imaging scan called dynamic LAFOV FDG-PET to help doctors better understand what's happening in your head and neck after you've finished radiation therapy for squamous cell carcinoma. About three months after your treatment ends, this special scan can show doctors whether any cancer cells remain or if what they're seeing is just normal healing inflammation from the radiation. The goal is to make it easier for doctors to decide what to do next.
After radiation therapy, it can be difficult for doctors to tell whether remaining activity in the treated area means cancer is still there or just inflammation from healing. This trial exists to see if this advanced scanning technique can answer that question more accurately and help guide the next steps in care.
You likely qualify if…
You likely don't qualify if…
You would return to the hospital about 3 months after finishing your radiation treatment to receive the special imaging scan. The scan itself involves receiving an injection of a mild radioactive dye and then lying still while the scanner takes detailed pictures over time. This is a single visit for observation and testing—there is no medication to take at home, and the study is designed to help doctors evaluate how well your treatment worked.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
France